3rd Quarter - Report
INTERNATIONAL MYELOMA FOUNDATION for INTERNATIONAL MYELOMA FOUNDATION
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Income
—
Expenses
$61,515
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Nov 4, 2020 | $61,515 | Replaced |
| 3rd Quarter - Amendment | Nov 19, 2020 | $66,733 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
CDMRP
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIELLE DOHENY | — |
| ROBIN R LEVY | — |
| RAYMOND LEE WEZIK | — |
Budget/Appropriations BUD
Department of Defense Cancer Research Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIELLE DOHENY | — |
| ROBIN R LEVY | — |
| RAYMOND LEE WEZIK | — |
Health Issues HCR
HR 1730/S.741 Cancer Issues - Multiple Myeloma
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIELLE DOHENY | — |
| ROBIN R LEVY | — |
| RAYMOND LEE WEZIK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.